News | February 24, 2024
Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
US FDA approval based on NEURO-TTRansform Phase III results
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
The inspection of the facility conducted from August 7 to August 11, 2023
Subscribe To Our Newsletter & Stay Updated
